Evotec SE (ETR:EVT)
7.40
+0.05 (0.71%)
May 13, 2025, 5:39 PM CET
Evotec SE Revenue
Evotec SE had revenue of 199.98M EUR in the quarter ending March 31, 2025, a decrease of -4.19%. This brings the company's revenue in the last twelve months to 788.22M, up 1.50% year-over-year. In the year 2024, Evotec SE had annual revenue of 796.97M with 1.99% growth.
Revenue (ttm)
788.22M
Revenue Growth
+1.50%
P/S Ratio
1.67
Revenue / Employee
165.38K
Employees
4,740
Market Cap
1.31B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 796.97M | 15.54M | 1.99% |
Dec 31, 2023 | 781.43M | 29.98M | 3.99% |
Dec 31, 2022 | 751.45M | 133.41M | 21.59% |
Dec 31, 2021 | 618.03M | 117.11M | 23.38% |
Dec 31, 2020 | 500.92M | 54.49M | 12.20% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Merck KGaA | 21.16B |
Siemens Healthineers AG | 23.14B |
Fresenius SE & Co. KGaA | 22.13B |
Bayer Aktiengesellschaft | 46.61B |
Fresenius Medical Care AG | 19.49B |
Sartorius Aktiengesellschaft | 3.44B |
Carl Zeiss Meditec AG | 2.08B |
Fielmann Group AG | 2.33B |
Evotec SE News
- 6 days ago - Evotec Receives $ 2.5 m Grant to Generate Next Generation Tuberculosis Treatments - Wallstreet:Online
- 6 days ago - Evotec Receives $ 2.5 m Grant to Generate Next Generation Tuberculosis Treatments - Accesswire
- 6 days ago - Evotec Secures $2.5M to Innovate TB Treatments! - Wallstreet:Online
- 6 days ago - EQS-News: Evotec receives $ 2.5 m grant to generate next generation tuberculosis treatments - Wallstreet:Online
- 7 days ago - Evotec SE 2025 Q1 - Results - Earnings Call Presentation - Seeking Alpha
- 7 days ago - Evotec SE (EVO) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 7 days ago - Evotec SE Reports Q1 2025 results: Paving the Way for 2025 Growth in Soft Market Environment - Wallstreet:Online
- 7 days ago - Evotec SE Reports Q1 2025 results: Paving the Way for 2025 Growth in Soft Market Environment - Accesswire